8th Int. Meeting STEROIDS and NERVOUS SYSTEM

Condividi su
Data dell'evento: dal 14/02/2015 al 18/02/2015
torino_1

Torino - February 14th-18th, 2015
8th International Meeting
STEROIDS and NERVOUS SYSTEM

After a very successful series of meetings (the last was in February 2013), we organized the 8th International meeting on Steroids and Nervous System, which will once again be held in Torino, between February 14th-18th, 2015.
As during the previous meetings, we will address state-of-the-art approaches in the field of steroids and nervous system, including behavior, epigenetics, genomic and non-genomic actions, aging, synaptic connectivity, psychiatric disorders.
A satellite symposium entirely dedicated to "Gender influence on neurodegenerative and psychiatric disorders" will be held the day 14.
The final scientific program is online.
Under 35 year-old can apply for fellowships.
 
Remember the Satellite Symposium the day 14, see the program here.
 
Roberto C. Melcangi (University of Milano, Italy) and GianCarlo Panzica (University of Torino - NICO, Italy)

Information: neurosteroids@unito.it - official website - Facebook

Agenda

16 febbraio 2019

Torino - 10th International Meeting STEROIDS and NERVOUS SYSTEM

Since 2001, this meeting represented an important event for basic and clinical researchers working on this emerging scientific topic. We will address state-of-the-art approaches in the field of steroids and nervous system, including behavior, epigenetics, genomic and non-genomic actions, the vitamin D, neurodegenerative and psychiatric disorders, and the interference among endocrine disruptors and steroid signaling.

Ricerca

Identificato un nuovo bersaglio per contrastare la SMA

L’inibizione della proteina JNK rallenta la progressione della malattia che colpisce i motoneuroni ed è la prima causa genetica di morte nell’infanzia. Lo dimostra uno studio pubblicato su Frontiers in Molecular Neuroscience dal nostro gruppo di ricerca guidato da Alessandro Vercelli, in collaborazione con l’Istituto Mario Negri di Milano. Chiarire i meccanismi molecolari alla base della SMA può aprire la strada allo sviluppo di nuove terapie.

24 ottobre 2018